Salus Pro - Benchtop Sequencing Platform Partner

Company Overview:
Salus Bio (Salus BioMed) is a leading provider of next-generation sequencing platforms designed for clinical diagnostics and research applications. The company specializes in developing cost-effective, high-performance benchtop sequencers that bring affordable, accessible sequencing solutions to clinical laboratories and research institutions. Salus Pro represents the company's medium-throughput sequencing platform.

Product Specialties & Applications:
Salus Pro is a multi-purpose benchtop sequencer providing high-quality genomic data with superior speed, compatibility, and affordability. The platform uses sequencing-by-synthesis technology and is engineered to meet diverse sequencing needs across industry and academic fields. Salus Pro supports various throughput levels (80M to 1000M reads per run) and data outputs (4Gb to 600Gb), with run times ranging from 4.8 to 42 hours, making it suitable for NIPT, shotgun metagenomics, large panel sequencing, and whole exome sequencing (WES).

Alignment with Mega Life Science:
Salus Pro's benchtop sequencing platform enhances Mega Life Science's distribution portfolio with accessible, cost-effective sequencing solutions. By offering Salus Pro's flexible sequencing platform, Mega Life Science provides customers with scalable sequencing capabilities for diverse clinical and research applications. The platform's rapid turnaround times and affordability make advanced genomic sequencing accessible to a broader range of laboratories.

Website: https://www.salus-bio.com/